Description
GLP-1S contains semaglutide, a GLP-1 receptor agonist extensively studied for its effects on appetite, satiety, glucose regulation, and body-weight management.
Semaglutide works by mimicking the activity of GLP-1 (glucagon-like peptide-1), a naturally occurring hormone involved in appetite and metabolic regulation. GLP-1 signaling can increase feelings of fullness, slow gastric emptying, reduce food intake, and support glucose-dependent insulin secretion.
Research Interests Include:
- Appetite and hunger regulation
- Increased satiety and fullness
- Body-weight and fat-mass changes
- Glucose metabolism
- Insulin response and metabolic function
- GLP-1 receptor signaling
10 mg vial | Research Use Only | Not for Human Consumption
